1.52 USD
↘ 0.13 (7.62%)LIVE (AS OF 02:00 PM EST)
Actinium Pharmaceuticals, Inc (ATNM) trades at $1.52 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (37.3%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest ATNM is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 13, 2026.